These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 7533414

  • 61. Recipient pretreatment with mammalian IL-10 prolongs mouse cardiac allograft survival by inhibition of anti-donor T cell responses.
    Li W, Fu F, Lu L, Narula SK, Fung JJ, Thomson AW, Qian S.
    Transplant Proc; 1999; 31(1-2):115. PubMed ID: 10083035
    [No Abstract] [Full Text] [Related]

  • 62. Ciprofloxacin upregulates interleukin-2 at the protein and mRNA levels in murine lymphocytes, but does not shorten graft survival in a rat cardiac allograft transplantation model.
    Riesbeck K, Schatz H, Ostraat O, Ekberg H, Forsgren A.
    Transplant Proc; 1992 Dec; 24(6):2558-9. PubMed ID: 1465865
    [No Abstract] [Full Text] [Related]

  • 63. [Biology of T-cells studied using monoclonal antibodies. I. Subpopulations of T-cell and monoclonal antibodies].
    Rupniewska ZM.
    Przegl Lek; 1984 Dec; 41(8):529-35. PubMed ID: 6240076
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. Treatment of murine cardiac allograft by monoclonal antibodies to IL-2 receptor alpha chain and beta chain.
    Isobe M, Suzuki J, Okubo Y, Horie S, Tanaka T, Miyasaka M, Sekiguchi M.
    Transplant Proc; 1997 Jun; 29(4):2301-2. PubMed ID: 9193630
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71. Cellular basis of passive enhancement of graft survival.
    Pearce NW, Dorsch SE, Hall BM.
    Transplant Proc; 1988 Feb; 20(1):53-5. PubMed ID: 2964113
    [No Abstract] [Full Text] [Related]

  • 72. OKT4A (a murine IgG2a anti-CD4 monoclonal antibody) in human organ transplantation: pharmacokinetics and peripheral pharmacodynamics.
    Henell KR, Cheever JM, Kimball JA, Lye WC, Munar MY, Misiti J, Vitow C, Norman DJ.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):800-1. PubMed ID: 8438489
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Function and migration of suppressor lymphocytes from cyclosporine-treated heart graft recipients.
    Bordes-Aznar J, Kupiec-Weglinski JW, Duarte AJ, Milford EL, Strom TB, Tilney NL.
    Transplantation; 1983 Feb; 35(2):185-90. PubMed ID: 6219479
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. [Monoclonal antibodies and transplantation].
    Hourmant M.
    Nephrologie; 1996 Feb; 17(8):435-40. PubMed ID: 9036366
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. A nondepleting anti-rat CD4 monoclonal antibody that suppresses T helper 1-like but not T helper 2-like intragraft lymphokine secretion induces long-term survival of renal allografts.
    Siegling A, Lehmann M, Riedel H, Platzer C, Brock J, Emmrich F, Volk HD.
    Transplantation; 1994 Feb; 57(3):464-7. PubMed ID: 8108886
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.